Table 3 Differences in prescription behaviour at baseline T0 for general practitioners and pain specialists who also participated at T2/ significant level is based on an independent two-tailed t-test

General Practitioners

 Prescription at baseline (T0)

Fact box

(n = 110)

Simulation

(n = 104)

p

Cohen‘s d

  WHO-III Opioids (strong)

23 ± 10.8

22.1 ± 10.9

.531

0.086

  NSAID

84.8 ± 15.7

87.6 ± 14

.172

-0.188

  WHO-II Opioids (weak)

12.3 ± 9.8

13.5 ± 11.5

.398

-0.116

  Multi-Modal Therapy

18 ± 13.1

16.8 ± 13.8

.503

0.092

  Physiotherapy/ Endurance Sports etc

67.2 ± 22.7

68 ± 21.7

.797

-0.035

  Psychotherapy

29.9 ± 24.3

29.1 ± 23.4

.824

0.031

  Means of Opioid Reduction

27.4 ± 22.4

26.1 ± 22.6

.675

0.057

Pain Specialists

 Prescription at baseline (T0)

Fact box

(n = 99)

Simulation

(n = 113)

p

Cohen ‘s d

  WHO-III Opioids (strong)

26.7 ± 12.2

258 ± 11.6

.586

0.075

  NSAID

74.9 ± 21.2

80 ± 20.6

.078

-0.244

  WHO-II Opioids (weak)

16.2 ± 13.5

14.9 ± 11.8

.459

0.102

  Multi-Modal Therapy

28.2 ± 17.3

26.2 ± 16.8

.395

0.117

  Physiotherapy/ Endurance Sports etc

65.2 ± 19.6

64 ± 19.1

.676

0.058

  Psychotherapy

50.4 ± 31.8

44.1 ± 30.9

.143

0.202

  Means of Opioid Reduction

46.9 ± 31.7

39 ± 30

.064

0.256